Protective effects of metformin in the pro-inflammatory cytokine induced intestinal organoids injury model
Biochemical and Biophysical Research Communications · 2024
DOI: 10.1016/j.bbrc.2023.149291 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Soojung Hahn und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul 06355, South Korea; Division of Endocrinology and Metabolism, De…. Hauptthemen laut MEDLINE: Metformin, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Abstract (Originalsprache)
Pathogenesis of inflammatory bowel disease (IBD) accompanies disrupted intestinal tight junctions. However, many approaches of therapeutics for IBD are focused only on anti-inflammatory effects and most cellular experiments are based on two-dimensional cell lines which have insufficient circumstances of intestine. Thus, here, we used three-dimensional structure intestinal organoids to investigate effects of metformin in the in vitro IBD condition. In this study, we focused on both tight junctions and the levels of inflammatory cytokines. Metformin enhances the intestinal barrier in injured intestine via upregulation of AMP-activated protein kinase, dysfunction of which contributes to the pathogenesis of intestinal diseases. We aim to investigate the effects of metformin on cytokine-induced injured intestinal organoids. Tumor necrosis factor-alpha (TNF-α) was used to induce intestinal injury in an organoid model, and the effects of metformin were assessed. Cell viability and levels of inflammatory cytokines were quantified in addition to tight junction markers. Furthermore, 4 kDa FITC-dextran was used to assess intestinal permeability. The upregulation of inflammatory cytokine levels was alleviated by metformin, which also restored the intestinal epithelium permeability in TNF-α-treated injury organoids. We confirmed that claudin-2 and claudin-7, representative tight junction markers, were also protected by metformin treatment. This study confirms the protective effects of metformin, which could be used as a therapeutic strategy for inflammatory intestinal diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul 06355, South Korea; Division of Endocrinology and Metabolism, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan Un…
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06355, South Korea. Electronic address: gyuri5.kim@samsung.com.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06355, South Korea. Electronic address: sangman.jin@samsung.com.
Zitieren
APA
Hahn, S., Kim, G., Jin, S. M., & Kim, J. H. (2024). Protective effects of metformin in the pro-inflammatory cytokine induced intestinal organoids injury model. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2023.149291
Vancouver
Hahn S, Kim G, Jin SM, Kim JH. Protective effects of metformin in the pro-inflammatory cytokine induced intestinal organoids injury model. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2023.149291
BibTeX
@article{Hahn2024,
author = {Hahn, Soojung and Kim, Gyuri and Jin, Sang-Man and Kim, Jae Hyeon},
title = {Protective effects of metformin in the pro-inflammatory cytokine induced intestinal organoids injury model},
journal = {Biochemical and Biophysical Research Communications},
year = {2024},
doi = {10.1016/j.bbrc.2023.149291}
}
EUVIMED